Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Colonic Neoplasms 70Rectal Neoplasms 67Colorectal Neoplasms 61Breast Neoplasms 26Pancreatic Neoplasms 15Head and Neck Neoplasms 13Neoplasm Metastasis 12Esophageal Neoplasms 11Squamous Cell Carcinoma of Head and Neck 10Unspecified Adult Solid Tumor, Protocol Specific 9Stomach Neoplasms 8Urinary Bladder Neoplasms 5Esophageal Squamous Cell Carcinoma 5Carcinoma, Renal Cell 5Carcinoma, Hepatocellular 5Adenocarcinoma Of Esophagus 5Ovarian Neoplasms 4Kidney Neoplasms 4Gallbladder Neoplasms 4Bile Duct Neoplasms 4Peritoneal Neoplasms 3Oropharyngeal Neoplasms 3Neoplasms 3Nasopharyngeal Neoplasms 3Lymphoma 3Hypopharyngeal Neoplasms 3Gastrointestinal Neoplasms 3Anus Neoplasms 3Uterine Cervical Dysplasia 2Salivary Gland Neoplasms 2

Interventions

Radiotherapy 2Psychiatric Rehabilitation 2Neoadjuvant Therapy 1Magnetic Resonance Spectroscopy 1Hyperbaric Oxygenation 1Fluorouracil 1Epirubicin 1Docetaxel 1Cyclophosphamide 1Biopsy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Postoperative Complications × Fluorouracil × Clear all
NCT01093235 2010-03-25

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
800 enrolled
Breast

Breast Neoplasms, Postoperative Complications, Breast Neoplasms, Male, Inflammatory Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡